Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-27 4:02 pm Purchase | 2025-10-20 | 13G | Alto Neuroscience, Inc. ANRO | Commodore Capital LP | 3,190,267 9.800% | 3,190,267 (New Position) | Filing History |
| 2025-10-08 4:09 pm Purchase | 2025-10-01 | 13G | Palisade Bio, Inc. PALI | Commodore Capital LP | 9,690,665 9.900% | 9,690,665 (New Position) | Filing History |
| 2025-10-03 4:05 pm Purchase | 2025-09-26 | 13G | SAB Biotherapeutics, Inc. SABS | Commodore Capital LP | 4,522,977 9.900% | 2,691,231 (+146.92%) | Filing History |
| 2025-09-18 4:01 pm Purchase | 2025-09-11 | 13G | LB Pharmaceuticals Inc Common Stock LBRX | Commodore Capital LP | 1,225,000 5.500% | 1,225,000 (New Position) | Filing History |
| 2025-09-16 6:00 pm Purchase | 2025-09-09 | 13G | Terns Pharmaceuticals, Inc. TERN | Commodore Capital LP | 4,650,000 5.300% | 4,650,000 (New Position) | Filing History |
| 2025-08-15 4:01 pm Purchase | 2025-08-08 | 13G | Assembly Biosciences, Inc. ASMB | Commodore Capital LP | 1,615,981 9.900% | 1,615,981 (New Position) | Filing History |
| 2025-08-14 5:07 pm Purchase | 2025-07-07 | 13G | Cogent Biosciences, Inc. COGT | Commodore Capital LP | 6,408,060 5.500% | 1,138,836 (+21.61%) | Filing History |
| 2025-08-14 5:07 pm Sale | 2025-06-30 | 13G | Solid Biosciences Inc. SLDB | Commodore Capital LP | 0 0.000% | -5,825,000 (Position Closed) | Filing History |
| 2025-08-14 5:07 pm Purchase | 2025-06-30 | 13G | Relay Therapeutics, Inc. RLAY | Commodore Capital LP | 13,350,000 7.800% | 3,350,000 (+33.50%) | Filing History |
| 2025-08-14 5:07 pm Sale | 2025-06-30 | 13G | Neurogene Inc. NGNE | Commodore Capital LP | 427,866 3.000% | -372,134 (-46.52%) | Filing History |
| 2025-08-14 5:06 pm Sale | 2025-06-30 | 13G | Merus N.V. MRUS | Commodore Capital LP | 3,525,000 4.700% | -225,000 (-6.00%) | Filing History |
| 2025-08-14 5:06 pm Purchase | 2025-06-30 | 13G | Enliven Therapeutics, Inc. ELVN | Commodore Capital LP | 6,022,957 9.900% | 1,922,957 (+46.90%) | Filing History |
| 2025-08-14 5:06 pm Sale | 2025-06-30 | 13G | Cardiff Oncology, Inc. CRDF | Commodore Capital LP | 0 0.000% | -5,384,616 (Position Closed) | Filing History |
| 2025-08-14 5:05 pm Sale | 2025-06-30 | 13G | Cogent Biosciences, Inc. COGT | Commodore Capital LP | 5,269,224 4.600% | -5,228,766 (-49.81%) | Filing History |
| 2025-07-02 4:32 pm Purchase | 2025-06-25 | 13G | Cidara Therapeutics, Inc. CDTX | Commodore Capital LP | 1,175,000 5.500% | 1,175,000 (New Position) | Filing History |
| 2025-05-15 4:05 pm Purchase | 2025-05-08 | 13G | Relay Therapeutics, Inc. RLAY | Commodore Capital LP | 10,000,000 5.800% | 10,000,000 (New Position) | Filing History |
| 2025-05-14 4:05 pm Purchase | 2025-05-07 | 13G | Tyra Biosciences, Inc. TYRA | Commodore Capital LP | 2,750,000 5.200% | 2,750,000 (New Position) | Filing History |
| 2025-04-11 5:15 pm Purchase | 2025-04-04 | 13G | Viridian Therapeutics, Inc. VRDN | Commodore Capital LP | 4,300,000 5.300% | 2,375,926 (+123.48%) | Filing History |
| 2025-04-10 4:05 pm Purchase | 2025-04-03 | 13G | Celldex Therapeutics, Inc. CLDX | Commodore Capital LP | 3,350,000 5.000% | 3,350,000 (New Position) | Filing History |
| 2025-02-25 4:05 pm Purchase | 2025-02-18 | 13G | Solid Biosciences Inc. SLDB | Commodore Capital LP | 5,825,000 7.600% | 5,825,000 (New Position) | Filing History |